Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15680275rdf:typepubmed:Citationlld:pubmed
pubmed-article:15680275lifeskim:mentionsumls-concept:C0006050lld:lifeskim
pubmed-article:15680275lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:15680275lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:15680275lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:15680275lifeskim:mentionsumls-concept:C0678793lld:lifeskim
pubmed-article:15680275pubmed:issue1-3lld:pubmed
pubmed-article:15680275pubmed:dateCreated2005-1-31lld:pubmed
pubmed-article:15680275pubmed:abstractTextBotulinum toxin is produced by Clostridium botulinum in three different molecular-weight forms: LL toxin, 900 kDa; L toxin, 500 kDa; and M toxin, 300 kDa. We isolated the M toxin, then compared its muscle-weakening efficacy with those of L+LL toxin and BOTOX both in vitro and in vivo. The twitch tension of the mouse isolated phrenic nerve-hemidiaphragm was used for the in vitro study. For the in vivo study, grip strength was measured in the toxin-injected legs. Undesirable muscle weakening was evaluated by grip-strength measurement in the contralateral leg. Concentration-response curves for effects on the phrenic nerve-hemidiaphragm showed that M toxin was 10 times more potent than L+LL toxin. The therapeutic index in vivo was 3- to 5-times higher for M toxin than for L+LL toxin or BOTOX, indicating a greater separation for M toxin between doses with local efficacy and systemic toxicity. These findings indicate that the M toxin preparation may have a better pharmacological profile than the conventional preparation.lld:pubmed
pubmed-article:15680275pubmed:languageenglld:pubmed
pubmed-article:15680275pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15680275pubmed:citationSubsetIMlld:pubmed
pubmed-article:15680275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15680275pubmed:statusMEDLINElld:pubmed
pubmed-article:15680275pubmed:monthJanlld:pubmed
pubmed-article:15680275pubmed:issn0014-2999lld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:SummersLinda...lld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:KatoMasanoriMlld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:ToriiYasushiYlld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:KozakiShunjiSlld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:SugimotoNakab...lld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:YonedaShinjiSlld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:ShimazawaMasa...lld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:NonoyamaAkira...lld:pubmed
pubmed-article:15680275pubmed:authorpubmed-author:NishinoHajime...lld:pubmed
pubmed-article:15680275pubmed:issnTypePrintlld:pubmed
pubmed-article:15680275pubmed:day31lld:pubmed
pubmed-article:15680275pubmed:volume508lld:pubmed
pubmed-article:15680275pubmed:ownerNLMlld:pubmed
pubmed-article:15680275pubmed:authorsCompleteYlld:pubmed
pubmed-article:15680275pubmed:pagination223-9lld:pubmed
pubmed-article:15680275pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:meshHeadingpubmed-meshheading:15680275...lld:pubmed
pubmed-article:15680275pubmed:year2005lld:pubmed
pubmed-article:15680275pubmed:articleTitleComparison of the therapeutic indexes of different molecular forms of botulinum toxin type A.lld:pubmed
pubmed-article:15680275pubmed:affiliationResearch and Development Center, Santen Pharmaceutical Co., Ltd., Nara, Japan. shinji.yoneda@santen.co.jplld:pubmed
pubmed-article:15680275pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15680275pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15680275pubmed:publicationTypeIn Vitrolld:pubmed